Several studies have also shown that CXCR3 expression on T cells, or expression of CXCL9 and CXCL10 in tumor tissue, is associated with increased TIL accumulation and a favourable clinical outcome in CRC [22–24]. The gene discussed is CXCL9; the disease is neoplasm.